{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:58:04Z","timestamp":1792789084034,"version":"4.5.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,12,6]],"date-time":"2014-12-06T00:00:00Z","timestamp":1417824000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s00415-014-7598-y","type":"journal-article","created":{"date-parts":[[2014,12,5]],"date-time":"2014-12-05T07:07:16Z","timestamp":1417763236000},"page":"1601-1612","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Diagnosis, investigation and management of hereditary spastic paraplegias in the era of next-generation sequencing"],"prefix":"10.1007","volume":"262","author":[{"given":"Anke","family":"Hensiek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Kirker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,6]]},"reference":[{"key":"7598_CR1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1055\/s-2008-1041143","volume":"13","author":"AE Harding","year":"1993","unstructured":"Harding AE (1993) Hereditary spastic paraplegias. Semin Neurol 13:333\u2013336","journal-title":"Semin Neurol"},{"key":"7598_CR2","volume-title":"The online metabolic and molecular bases of inherited diseases","author":"E Reid","year":"2010","unstructured":"Reid E, Rugarli E (2010) Hereditary spastic paraplegias. In: Valle D et al (eds) The online metabolic and molecular bases of inherited diseases. McGraw Hill, New York"},{"key":"7598_CR3","volume-title":"The hereditary ataxias and related disorders","author":"AE Harding","year":"1984","unstructured":"Harding AE (1984) The hereditary ataxias and related disorders. Churchill Livingston, Edinburgh"},{"key":"7598_CR4","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000358801","volume":"42","author":"L Ruano","year":"2014","unstructured":"Ruano L, Melo C, Silva MC, Coutinho P (2014) The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies. Neuroepidemiology 42:174\u2013183","journal-title":"Neuroepidemiology"},{"key":"7598_CR5","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/jnnp.44.10.871","volume":"44","author":"AE Harding","year":"1981","unstructured":"Harding AE (1981) Hereditary \u201cpure\u201d spastic paraplegia: a clinical and genetic study of 22 families. J Neurol Neurosurg Psychiatry 44:871\u2013883","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Pt 9","key":"7598_CR6","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1093\/brain\/122.9.1741","volume":"122","author":"E Reid","year":"1999","unstructured":"Reid E, Grayson C, Rogers MT, Rubinsztein DC (1999) Locus-phenotype correlations in autosomal dominant pure hereditary spastic paraplegia. A clinical and molecular genetic study of 28 United Kingdom families. Brain 122(Pt 9):1741\u20131755","journal-title":"Brain"},{"key":"7598_CR7","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1212\/WNL.44.7.1274","volume":"44","author":"A Durr","year":"1994","unstructured":"Durr A et al (1994) The phenotype of \u201cpure\u201d autosomal dominant spastic paraplegia. Neurology 44:1274\u20131277","journal-title":"Neurology"},{"key":"7598_CR8","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/jmg.34.6.499","volume":"34","author":"E Reid","year":"1997","unstructured":"Reid E (1997) Pure hereditary spastic paraplegia. J Med Genet 34:499\u2013503","journal-title":"J Med Genet"},{"key":"7598_CR9","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1212\/WNL.46.6.1507","volume":"46","author":"JK Fink","year":"1996","unstructured":"Fink JK et al (1996) Hereditary spastic paraplegia: advances in genetic research. Hereditary Spastic Paraplegia Working group. Neurology 46:1507\u20131514","journal-title":"Neurology"},{"key":"7598_CR10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1399-0004.2009.01176.x","volume":"75","author":"A Boukhris","year":"2009","unstructured":"Boukhris A et al (2009) Tunisian hereditary spastic paraplegias: clinical variability supported by genetic heterogeneity. Clin Genet 75:527\u2013536","journal-title":"Clin Genet"},{"key":"7598_CR11","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1083\/jcb.201403026","volume":"205","author":"A Gerondopoulos","year":"2014","unstructured":"Gerondopoulos A et al (2014) Rab18 and a Rab18 GEF complex are required for normal ER structure. J Cell Biol 205:707\u2013720","journal-title":"J Cell Biol"},{"key":"7598_CR12","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1468-1331.2004.00888.x","volume":"11","author":"JE Nielsen","year":"2004","unstructured":"Nielsen JE et al (2004) Hereditary spastic paraplegia with cerebellar ataxia: a complex phenotype associated with a new SPG4 gene mutation. Eur J Neurol 11:817\u2013824","journal-title":"Eur J Neurol"},{"key":"7598_CR13","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/archneur.64.5.706","volume":"64","author":"N Ivanova","year":"2007","unstructured":"Ivanova N et al (2007) Hereditary spastic paraplegia 3A associated with axonal neuropathy. Arch Neurol 64:706\u2013713","journal-title":"Arch Neurol"},{"key":"7598_CR14","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/humu.21542","volume":"32","author":"C Goizet","year":"2011","unstructured":"Goizet C et al (2011) REEP1 mutations in SPG31: frequency, mutational spectrum, and potential association with mitochondrial morpho-functional dysfunction. Hum Mutat 32:1118\u20131127","journal-title":"Hum Mutat"},{"key":"7598_CR15","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/brain\/awp056","volume":"132","author":"AK Erichsen","year":"2009","unstructured":"Erichsen AK, Koht J, Stray-Pedersen A, Abdelnoor M, Tallaksen CM (2009) Prevalence of hereditary ataxia and spastic paraplegia in southeast Norway: a population-based study. Brain 132:1577\u20131588","journal-title":"Brain"},{"key":"7598_CR16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10048-007-0090-4","volume":"8","author":"C Depienne","year":"2007","unstructured":"Depienne C et al (2007) A de novo SPAST mutation leading to somatic mosaicism is associated with a later age at onset in HSP. Neurogenetics 8:231\u2013233","journal-title":"Neurogenetics"},{"key":"7598_CR17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/jmg.2006.046425","volume":"44","author":"C Depienne","year":"2007","unstructured":"Depienne C et al (2007) Exon deletions of SPG4 are a frequent cause of hereditary spastic paraplegia. J Med Genet 44:281\u2013284","journal-title":"J Med Genet"},{"key":"7598_CR18","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1212\/01.wnl.0000244413.49258.f5","volume":"67","author":"C Beetz","year":"2006","unstructured":"Beetz C et al (2006) High frequency of partial SPAST deletions in autosomal dominant hereditary spastic paraplegia. Neurology 67:1926\u20131930","journal-title":"Neurology"},{"key":"7598_CR19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10072-011-0899-3","volume":"34","author":"A Sulek","year":"2013","unstructured":"Sulek A et al (2013) Screening for the hereditary spastic paraplaegias SPG4 and SPG3A with the multiplex ligation-dependent probe amplification technique in a large population of affected individuals. Neurol Sci 34:239\u2013242","journal-title":"Neurol Sci"},{"key":"7598_CR20","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/ng1980","volume":"39","author":"G Stevanin","year":"2007","unstructured":"Stevanin G et al (2007) Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum. Nat Genet 39:366\u2013372","journal-title":"Nat Genet"},{"key":"7598_CR21","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/brain\/awm293","volume":"131","author":"G Stevanin","year":"2008","unstructured":"Stevanin G et al (2008) Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration. Brain 131:772\u2013784","journal-title":"Brain"},{"key":"7598_CR22","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.ajhg.2008.03.004","volume":"82","author":"S Hanein","year":"2008","unstructured":"Hanein S et al (2008) Identification of the SPG15 gene, encoding spastizin, as a frequent cause of complicated autosomal-recessive spastic paraplegia, including Kjellin syndrome. Am J Hum Genet 82:992\u20131002","journal-title":"Am J Hum Genet"},{"key":"7598_CR23","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1091\/mbc.E13-03-0170","volume":"24","author":"J Hirst","year":"2013","unstructured":"Hirst J et al (2013) Interaction between AP-5 and the hereditary spastic paraplegia proteins SPG11 and SPG15. Mol Biol Cell 24:2558\u20132569","journal-title":"Mol Biol Cell"},{"key":"7598_CR24","doi-asserted-by":"crossref","first-page":"e1001170","DOI":"10.1371\/journal.pbio.1001170","volume":"9","author":"J Hirst","year":"2011","unstructured":"Hirst J et al (2011) The fifth adaptor protein complex. PLoS Biol 9:e1001170","journal-title":"PLoS Biol"},{"key":"7598_CR25","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1093\/brain\/awu121","volume":"137","author":"V Pensato","year":"2014","unstructured":"Pensato V et al (2014) Overlapping phenotypes in complex spastic paraplegias SPG11, SPG15, SPG35 and SPG48. Brain 137:1907\u20131920","journal-title":"Brain"},{"key":"7598_CR26","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/ene.12341","volume":"21","author":"BPC Warrenburg van de","year":"2014","unstructured":"van de Warrenburg BPC et al (2014) EFNS\/ENS Consensus on the diagnosis and management of chronic ataxias in adulthood. Eur J Neurol 21:552\u2013562","journal-title":"Eur J Neurol"},{"key":"7598_CR27","first-page":"279","volume":"3","author":"F Sedel","year":"2007","unstructured":"Sedel F, Lyon-Caen O, Saudubray JM (2007) Therapy insight: inborn errors of metabolism in adult neurology\u2013\u2013a clinical approach focused on treatable diseases. Nature clinical practice. Neurology 3:279\u2013290","journal-title":"Neurology"},{"key":"7598_CR28","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1212\/WNL.0b013e3181fc2776","volume":"75","author":"ST Bot de","year":"2010","unstructured":"de Bot ST, van de Warrenburg BP, Kremer HP, Willemsen MA (2010) Child neurology: hereditary spastic paraplegia in children. Neurology 75:e75\u2013e79","journal-title":"Neurology"},{"key":"7598_CR29","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/jnnp-2013-306981","volume":"85","author":"H Shimazaki","year":"2014","unstructured":"Shimazaki H et al (2014) Autosomal-recessive complicated spastic paraplegia with a novel lysosomal trafficking regulator gene mutation. J Neurol Neurosurg Psychiatry 85:1024\u20131028","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7598_CR30","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/brain\/awp073","volume":"132","author":"C Goizet","year":"2009","unstructured":"Goizet C et al (2009) CYP7B1 mutations in pure and complex forms of hereditary spastic paraplegia type 5. Brain 132:1589\u20131600","journal-title":"Brain"},{"key":"7598_CR31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jns.2009.06.027","volume":"285","author":"Y-G Wang","year":"2009","unstructured":"Wang Y-G et al (2009) Six cases of SCA3\/MJD patients that mimic hereditary spastic paraplegia in clinic. J Neurol Sci 285:121\u2013124","journal-title":"J Neurol Sci"},{"key":"7598_CR32","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1212\/WNL.0b013e31826d5fb0","volume":"79","author":"ST Bot de","year":"2012","unstructured":"de Bot ST, Willemsen MA, Vermeer S, Kremer HP, van de Warrenburg BP (2012) Reviewing the genetic causes of spastic-ataxias. Neurology 79:1507\u20131514","journal-title":"Neurology"},{"key":"7598_CR33","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0092-8674(00)81203-9","volume":"93","author":"G Casari","year":"1998","unstructured":"Casari G et al (1998) Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 93:973\u2013983","journal-title":"Cell"},{"key":"7598_CR34","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/brain\/awh125","volume":"127","author":"PA Wilkinson","year":"2004","unstructured":"Wilkinson PA et al (2004) A clinical, genetic and biochemical study of SPG7 mutations in hereditary spastic paraplegia. Brain 127:973\u2013980","journal-title":"Brain"},{"key":"7598_CR35","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ajhg.2012.07.018","volume":"91","author":"V Bourassa Cynthia","year":"2012","unstructured":"Bourassa Cynthia V et al (2012) VAMP1 mutation causes dominant hereditary spastic ataxia in newfoundland families. Am J Hum Genet 91:548\u2013552","journal-title":"Am J Hum Genet"},{"key":"7598_CR36","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1001\/archneur.60.12.1791","volume":"60","author":"AH Ropper","year":"2003","unstructured":"Ropper AH, Ayata C, Adelman L (2003) Vasculitis of the spinal cord. Arch Neurol 60:1791\u20131794","journal-title":"Arch Neurol"},{"key":"7598_CR37","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S1474-4422(06)70628-7","volume":"5","author":"AQ Araujo","year":"2006","unstructured":"Araujo AQ, Silva MT (2006) The HTLV-1 neurological complex. Lancet Neurol 5:1068\u20131076","journal-title":"Lancet Neurol"},{"key":"7598_CR38","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0140-6736(95)11035-6","volume":"348","author":"RW Price","year":"1996","unstructured":"Price RW (1996) Neurological complications of HIV infection. Lancet 348:445\u2013452","journal-title":"Lancet"},{"key":"7598_CR39","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1212\/WNL.56.2.260","volume":"56","author":"Y Furukawa","year":"2001","unstructured":"Furukawa Y, Graf WD, Wong H, Shimadzu M, Kish SJ (2001) Dopa-responsive dystonia simulating spastic paraplegia due to tyrosine hydroxylase (TH) gene mutations. Neurology 56:260\u2013263","journal-title":"Neurology"},{"key":"7598_CR40","doi-asserted-by":"crossref","first-page":"E2393","DOI":"10.1002\/humu.22376","volume":"34","author":"X Liu","year":"2013","unstructured":"Liu X, Jian X, Boerwinkle E (2013) dbNSFP v2.0: a database of human non-synonymous SNVs and their functional predictions and annotations. Hum Mutat 34:E2393\u2013E2402","journal-title":"Hum Mutat"},{"key":"7598_CR41","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/jamaneurol.2013.2068","volume":"70","author":"A Pittman","year":"2013","unstructured":"Pittman A, Hardy J (2013) Genetic analysis in neurology: the next 10 years. JAMA Neurol 70:696\u2013702","journal-title":"JAMA Neurol"},{"key":"7598_CR42","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/gim.2013.133","volume":"15","author":"JS Berg","year":"2013","unstructured":"Berg JS et al (2013) Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium. Genet Med 15:860\u2013867","journal-title":"Genet Med"},{"key":"7598_CR43","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1177\/0883073809356037","volume":"25","author":"K Geva-Dayan","year":"2010","unstructured":"Geva-Dayan K, Domenievitz D, Zahalka R, Fattal-Valevski A (2010) Botulinum toxin injections for pediatric patients with hereditary spastic paraparesis. J Child Neurol 25:969\u2013975","journal-title":"J Child Neurol"},{"key":"7598_CR44","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1161\/STROKEAHA.111.000334","volume":"44","author":"PM Kluding","year":"2013","unstructured":"Kluding PM et al (2013) Foot drop stimulation versus ankle foot orthosis after stroke: 30-week outcomes. Stroke 44:1660\u20131669","journal-title":"Stroke"},{"key":"7598_CR45","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00590-012-1049-1","volume":"23","author":"MT Karimi","year":"2013","unstructured":"Karimi MT (2013) Functional walking ability of paraplegic patients: comparison of functional electrical stimulation versus mechanical orthoses. Eur J Orthop Surg Traumatol orthop traumatol 23:631\u2013638","journal-title":"Eur J Orthop Surg Traumatol orthop traumatol"},{"key":"7598_CR46","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1177\/1545968314521007","volume":"28","author":"F Bethoux","year":"2014","unstructured":"Bethoux F et al (2014) The effects of peroneal nerve functional electrical stimulation versus ankle-foot orthosis in patients with chronic stroke: a randomized controlled trial. Neurorehab Neural Repair 28:688\u2013697","journal-title":"Neurorehab Neural Repair"},{"key":"7598_CR47","first-page":"794","volume":"73","author":"JM Meythaler","year":"1992","unstructured":"Meythaler JM et al (1992) Intrathecal baclofen in hereditary spastic paraparesis. Arch Phys Med Rehabil 73:794\u2013797","journal-title":"Arch Phys Med Rehabil"},{"key":"7598_CR48","doi-asserted-by":"crossref","unstructured":"Lambrecq V et al. (2007) Intrathecal baclofen in hereditary spastic paraparesis: benefits and limitations. Annales de readaptation et de medecine physique : revue scientifique de la Societe francaise de reeducation fonctionnelle de readaptation et de medecine physique 50:577\u2013581","DOI":"10.1016\/j.annrmp.2007.02.009"},{"key":"7598_CR49","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/hmg\/9.4.637","volume":"9","author":"N Fonknechten","year":"2000","unstructured":"Fonknechten N et al (2000) Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia. Hum Mol Genet 9:637\u2013644","journal-title":"Hum Mol Genet"},{"key":"7598_CR50","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/humu.9340","volume":"25","author":"C Patrono","year":"2005","unstructured":"Patrono C et al (2005) Autosomal dominant hereditary spastic paraplegia: DHPLC-based mutation analysis of SPG4 reveals eleven novel mutations. Hum Mutat 25:506","journal-title":"Hum Mutat"},{"key":"7598_CR51","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/humu.10105","volume":"20","author":"S Sauter","year":"2002","unstructured":"Sauter S et al (2002) Mutation analysis of the spastin gene (SPG4) in patients in Germany with autosomal dominant hereditary spastic paraplegia. Hum Mutat 20:127\u2013132","journal-title":"Hum Mutat"},{"key":"7598_CR52","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/ejhg.2008.147","volume":"17","author":"M Shoukier","year":"2009","unstructured":"Shoukier M et al (2009) Expansion of mutation spectrum, determination of mutation cluster regions and predictive structural classification of SPAST mutations in hereditary spastic paraplegia. Eur J Hum Genet 17:187\u2013194","journal-title":"Eur J Hum Genet"},{"key":"7598_CR53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj20011706","volume":"J367","author":"HA Meijer","year":"2002","unstructured":"Meijer HA, Thomas AA (2002) Control of eukaryotic protein synthesis by upstream open reading frames in the 5\u2032-untranslated region of an mRNA. Biochem J367:1\u201311","journal-title":"Biochem"},{"key":"7598_CR54","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1001\/archneur.62.7.1118","volume":"62","author":"SY Park","year":"2005","unstructured":"Park SY et al (2005) Mutation analysis of SPG4 and SPG3A genes and its implication in molecular diagnosis of Korean patients with hereditary spastic paraplegia. Arch Neurol 62:1118\u20131121","journal-title":"Arch Neurol"},{"key":"7598_CR55","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/jmg.2005.035311","volume":"43","author":"C Depienne","year":"2006","unstructured":"Depienne C et al (2006) Spastin mutations are frequent in sporadic spastic paraparesis and their spectrum is different from that observed in familial cases. J Med Genet 43:259\u2013265","journal-title":"J Med Genet"},{"key":"7598_CR56","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/archneur.63.5.750","volume":"63","author":"F Crippa","year":"2006","unstructured":"Crippa F et al (2006) Eight novel mutations in SPG4 in a large sample of patients with hereditary spastic paraplegia. Arch Neurol 63:750\u2013755","journal-title":"Arch Neurol"},{"key":"7598_CR57","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/ana.20652","volume":"58","author":"F Brugman","year":"2005","unstructured":"Brugman F et al (2005) Spastin mutations in sporadic adult-onset upper motor neuron syndromes. Ann Neurol 58:865\u2013869","journal-title":"Ann Neurol"},{"key":"7598_CR58","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000177033","volume":"32","author":"M Braschinsky","year":"2009","unstructured":"Braschinsky M, Luus SM, Gross-Paju K, Haldre S (2009) The prevalence of hereditary spastic paraplegia and the occurrence of SPG4 mutations in Estonia. Neuroepidemiology 32:89\u201393","journal-title":"Neuroepidemiology"},{"key":"7598_CR59","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10048-004-0191-2","volume":"5","author":"A Abel","year":"2004","unstructured":"Abel A et al (2004) Early onset autosomal dominant spastic paraplegia caused by novel mutations in SPG3A. Neurogenetics 5:239\u2013243","journal-title":"Neurogenetics"},{"key":"7598_CR60","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1001\/archneur.61.12.1867","volume":"61","author":"A Durr","year":"2004","unstructured":"Durr A et al (2004) Atlastin1 mutations are frequent in young-onset autosomal dominant spastic paraplegia. Arch Neurol 61:1867\u20131872","journal-title":"Arch Neurol"},{"key":"7598_CR61","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/ng758","volume":"29","author":"X Zhao","year":"2001","unstructured":"Zhao X et al (2001) Mutations in a newly identified GTPase gene cause autosomal dominant hereditary spastic paraplegia. Nat Genet 29:326\u2013331","journal-title":"Nat Genet"},{"key":"7598_CR62","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1471-2350-9-71","volume":"9","author":"KJ Schlang","year":"2008","unstructured":"Schlang KJ, Arning L, Epplen JT, Stemmler S (2008) Autosomal dominant hereditary spastic paraplegia: novel mutations in the REEP1 gene (SPG31). BMC Med Genet 9:71","journal-title":"BMC Med Genet"},{"key":"7598_CR63","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/brain\/awn026","volume":"131","author":"C Beetz","year":"2008","unstructured":"Beetz C et al (2008) REEP1 mutation spectrum and genotype\/phenotype correlation in hereditary spastic paraplegia type 31. Brain 131:1078\u20131086","journal-title":"Brain"},{"key":"7598_CR64","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10048-008-0163-z","volume":"10","author":"C Hewamadduma","year":"2009","unstructured":"Hewamadduma C et al (2009) New pedigrees and novel mutation expand the phenotype of REEP1-associated hereditary spastic paraplegia (HSP). Neurogenetics 10:105\u2013110","journal-title":"Neurogenetics"},{"key":"7598_CR65","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1086\/505361","volume":"79","author":"S Zuchner","year":"2006","unstructured":"Zuchner S et al (2006) Mutations in the novel mitochondrial protein REEP1 cause hereditary spastic paraplegia type 31. Am J Hum Genet 79:365\u2013369","journal-title":"Am J Hum Genet"},{"key":"7598_CR66","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/jnnp.2007.137596","volume":"79","author":"R Schule","year":"2008","unstructured":"Schule R et al (2008) SPG10 is a rare cause of spastic paraplegia in European families. J Neurol Neurosurg Psychiatry 79:584\u2013587","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7598_CR67","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1007\/s00415-008-0840-8","volume":"255","author":"A Tessa","year":"2008","unstructured":"Tessa A et al (2008) A novel KIF5A\/SPG10 mutation in spastic paraplegia associated with axonal neuropathy. J Neurol 255:1090\u20131092","journal-title":"J Neurol"},{"key":"7598_CR68","doi-asserted-by":"crossref","first-page":"E376","DOI":"10.1002\/humu.20920","volume":"30","author":"C Goizet","year":"2009","unstructured":"Goizet C et al (2009) Complicated forms of autosomal dominant hereditary spastic paraplegia are frequent in SPG10. Hum Mutat 30:E376\u2013E385","journal-title":"Hum Mutat"},{"key":"7598_CR69","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1086\/510782","volume":"80","author":"PN Valdmanis","year":"2007","unstructured":"Valdmanis PN et al (2007) Mutations in the KIAA0196 gene at the SPG8 locus cause hereditary spastic paraplegia. Am J Hum Genet 80:152\u2013161","journal-title":"Am J Hum Genet"},{"key":"7598_CR70","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s00415-013-6870-x","volume":"260","author":"S Bot de","year":"2013","unstructured":"de Bot S et al (2013) Pure adult-onset Spastic Paraplegia caused by a novel mutation in the KIAA0196 (SPG8) gene. J Neurol 260:1765\u20131769","journal-title":"J Neurol"},{"key":"7598_CR71","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1172\/JCI60560","volume":"122","author":"G Montenegro","year":"2012","unstructured":"Montenegro G et al (2012) Mutations in the ER-shaping protein reticulon 2 cause the axon-degenerative disorder hereditary spastic paraplegia type 12. J Clin Investig 122:538\u2013544","journal-title":"J Clin Investig"},{"key":"7598_CR72","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jns.2007.11.015","volume":"268","author":"C Beetz","year":"2008","unstructured":"Beetz C et al (2008) Screening of hereditary spastic paraplegia patients for alterations at NIPA1 mutational hotspots. J Neurol Sci 268:131\u2013135","journal-title":"J Neurol Sci"},{"key":"7598_CR73","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10048-006-0074-9","volume":"8","author":"S Klebe","year":"2007","unstructured":"Klebe S et al (2007) NIPA1 (SPG6) mutations are a rare cause of autosomal dominant spastic paraplegia in Europe. Neurogenetics 8:155\u2013157","journal-title":"Neurogenetics"},{"key":"7598_CR74","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1212\/01.wnl.0000319700.11606.21","volume":"71","author":"F Brugman","year":"2008","unstructured":"Brugman F et al (2008) Paraplegin mutations in sporadic adult-onset upper motor neuron syndromes. Neurology 71:1500\u20131505","journal-title":"Neurology"},{"key":"7598_CR75","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/humu.20682","volume":"29","author":"A Arnoldi","year":"2008","unstructured":"Arnoldi A et al (2008) A clinical, genetic, and biochemical characterization of SPG7 mutations in a large cohort of patients with hereditary spastic paraplegia. Hum Mutat 29:522\u2013531","journal-title":"Hum Mutat"},{"key":"7598_CR76","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1212\/01.wnl.0000201185.91110.15","volume":"66","author":"N Elleuch","year":"2006","unstructured":"Elleuch N et al (2006) Mutation analysis of the paraplegin gene (SPG7) in patients with hereditary spastic paraplegia. Neurology 66:654\u2013659","journal-title":"Neurology"},{"key":"7598_CR77","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1055\/s-2002-36535","volume":"22","author":"LP Caragine Jr","year":"2002","unstructured":"Caragine LP Jr, Halbach VV, Ng PP, Dowd CF (2002) Vascular myelopathies-vascular malformations of the spinal cord: presentation and endovascular surgical management. Semin Neurol 22:123\u2013132","journal-title":"Semin Neurol"},{"key":"7598_CR78","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/jnnp.65.5.633","volume":"65","author":"RA Barker","year":"1998","unstructured":"Barker RA, Revesz T, Thom M, Marsden CD, Brown P (1998) Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressive encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry 65:633\u2013640","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7598_CR79","first-page":"965","volume":"98","author":"S Saleh","year":"2006","unstructured":"Saleh S, Saw C, Marzouk K, Sharma O (2006) Sarcoidosis of the spinal cord: literature review and report of eight cases. J Natl Med Assoc 98:965\u2013976","journal-title":"J Natl Med Assoc"},{"key":"7598_CR80","first-page":"894","volume":"19","author":"PJ Pema","year":"1998","unstructured":"Pema PJ, Horak HA, Wyatt RH (1998) Myelopathy caused by nitrous oxide toxicity. AJNR Am J Neuroradiol 19:894\u2013896","journal-title":"AJNR Am J Neuroradiol"},{"key":"7598_CR81","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/jnnp.2003.022970","volume":"75","author":"CJ Shaw-Smith","year":"2004","unstructured":"Shaw-Smith CJ, Lewis SJ, Reid E (2004) X-linked adrenoleukodystrophy presenting as autosomal dominant pure hereditary spastic paraparesis. J Neurol Neurosurg Psychiatry 75:686\u2013688","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7598_CR82","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/ene.12423","volume":"21","author":"J M\u00fcller vom Hagen","year":"2014","unstructured":"M\u00fcller vom Hagen J, Karle KN, Sch\u00fcle R, Kr\u00e4geloh-Mann I, Sch\u00f6ls L (2014) Leukodystrophies underlying cryptic spastic paraparesis: frequency and phenotype in 76 patients. Eur J Neurol 21:983\u2013988","journal-title":"Eur J Neurol"},{"key":"7598_CR83","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00415-010-5511-x","volume":"257","author":"SR Jaiser","year":"2010","unstructured":"Jaiser SR, Winston GP (2010) Copper deficiency myelopathy. J Neurol 257:869\u2013881","journal-title":"J Neurol"},{"key":"7598_CR84","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/mpo.2950150208","volume":"15","author":"JW Goldwein","year":"1987","unstructured":"Goldwein JW (1987) Radiation myelopathy: a review. Med Pediatr Oncol 15:89\u201395","journal-title":"Med Pediatr Oncol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-014-7598-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-014-7598-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-014-7598-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T19:14:51Z","timestamp":1551208491000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-014-7598-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,6]]},"references-count":84,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["7598"],"URL":"https:\/\/doi.org\/10.1007\/s00415-014-7598-y","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,6]]}}}